Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$3.53 - $12.21 $70,600 - $244,200
-20,000 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$13.91 - $19.87 $278,200 - $397,400
-20,000 Reduced 50.0%
20,000 $312,000
Q2 2019

Aug 14, 2019

BUY
$13.19 - $28.36 $527,600 - $1.13 Million
40,000 New
40,000 $585,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.